(Q41205482)

28 September 2017

1 reference

title

NK cell proliferation and inflammation (English)

1 reference

28 September 2017

Warren HS

1

1 reference

28 September 2017

1 October 1996

1 reference

Immunology & Cell Biology

28 September 2017

1 reference

28 September 2017

74

1 reference

28 September 2017

5

1 reference

28 September 2017

473-480

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.1996.78

28 September 2017

0 references

cites work

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Human natural killer (NK) cells: requirements for cell proliferation and expansion of phenotypically novel subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Evidence for three types of human cytotoxic lymphocyte

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Molecular associations involving CD16, CD45 and zeta and gamma chains on human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

A glycolipid on the surface of mouse natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

The murine NK2.1 antigen: a 130 kD glycoprotein dimer expressed by a natural killer cell subset of the spleen, thymus and lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

https://api.crossref.org/works/10.1038%2FICB.1996.78

1 reference

7 January 2021

Mouse NK1.1+ T cells: a new family of T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

A cyclophilin-related protein involved in the function of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Inhibitory MHC class I receptors on NK cells and T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

A family of murine NK cell receptors specific for target cell MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Isolation of human NK cells by density gradient centrifugation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Granulated metrial gland cells: hypotheses concerning possible functions during murine gestation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

NKR-P1+ cells in the rat uterus: granulated metrial gland cells are of the natural killer cell lineage

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Uterine granular lymphocytes are activated natural killer cells expressing VLA-1

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Accumulation of CD16−CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

On the nature and function of human uterine granular lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Leu 7+ (HNK-1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

NK cells in non-neoplastic lung tissue. Initial results

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Recent advances in the pathogenesis of reactive arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Presence of natural killer cells in human chronic periapical lesions.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Human NK cells expressing alpha 4 beta 1/beta 7 adhere to VCAM-1 without preactivation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Fibronectin facilitates the migration of human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Comparative analysis of the immunophenotypes of decidual and peripheral blood large granular lymphocytes and T cells during early human pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Passenger lymphocytes in human liver allografts and their potential role after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Proliferation of alloreactive human natural killer cells independent of specific allogeneic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Cyclosporin inhibits a two-signal mechanism for the generation of cytotoxic NK-like cells, from small lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Differential expression of CD45R0 on natural killer (NK) cells in patients with an NK lymphocytosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.78

7 January 2021

Identifiers

DOI

10.1038/ICB.1996.78

1 reference

PubMed ID

8912011

Dimensions Publication ID

28 September 2017

0 references

1 reference

PubMed ID

8912011